Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 16Pancreatic Neoplasms 9Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Melanoma 5Ovarian Neoplasms 4Neoplasm Metastasis 4Carcinoma, Merkel Cell 4Turcot syndrome 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Transitional Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Microsatellite Instability 2Gastrointestinal Neoplasms 2Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Cancer Resectable 1Mesothelioma, Malignant 1Liver Diseases 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × avelumab × Gastrointestinal × Clear all
NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03812796 2019-02-05

EMERGE

Royal Marsden NHS Foundation Trust

Phase 2 Unknown
75 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡